当前位置:首页 - 行情中心 - 迪哲医药-U(688192) - 财务分析

迪哲医药-U

(688192)

  

流通市值:296.77亿  总市值:332.75亿
流通股本:4.10亿   总股本:4.59亿

迪哲医药-U(688192)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润-3.79亿元,每股收益-0.87元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益162877.75万元,未分配利润-373688.13万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产321846.06万元,负债158968.31万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入355,001,420.82159,641,464.34359,900,621.06338,451,000
营业总成本779,607,061.37382,021,501.251,356,850,887.841,031,763,876.35
其他经营收益
营业利润-378,990,328-193,740,729.91-941,301,044.88-651,046,906.08
利润总额-378,990,328-193,740,729.91-939,651,337.2-649,643,945.08
净利润-379,042,400.14-193,740,729.91-939,655,188.7-649,647,448.06
每股收益
其他综合收益----
综合收益总额-379,042,400.14-193,740,729.91-939,655,188.7-649,647,448.06
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计2,404,927,026.781,020,706,852.37998,972,803.78976,922,487.65
非流动资产:
非流动资产合计813,533,558.53784,132,605.39719,765,080.27665,586,569.93
资产总计3,218,460,585.311,804,839,457.761,718,737,884.051,642,509,057.58
流动负债:
流动负债合计888,200,263.76893,263,177.75785,084,502.82566,900,903.06
非流动负债:
非流动负债合计701,482,796.21888,042,173.06733,596,483.6638,361,287.92
负债合计1,589,683,059.971,781,305,350.811,518,680,986.421,205,262,190.98
所有者权益(或股东权益):
归属于母公司股东权益合计1,624,158,702.7118,460,390.68193,755,800.4428,433,784.72
股东权益合计1,628,777,525.3423,534,106.95200,056,897.63437,246,866.6
负债和股东权益合计3,218,460,585.311,804,839,457.761,718,737,884.051,642,509,057.58
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计382,022,208.42189,480,497.17485,100,641.45387,967,942.27
经营活动现金流出小计646,691,577.16321,147,456.631,135,626,105.72851,276,282.69
经营活动产生的现金流量净额-264,669,368.74-131,666,959.46-650,525,464.27-463,308,340.42
投资活动产生的现金流量:
投资活动现金流入小计3,631,604,581.35732,182,713.484,018,911,576.932,709,870,267.04
投资活动现金流出小计4,148,832,364.76860,832,800.064,056,985,882.852,796,486,925.33
投资活动产生的现金流量净额-517,227,783.41-128,650,086.58-38,074,305.92-86,616,658.29
筹资活动产生的现金流量:
筹资活动现金流入小计2,333,585,746.05391,343,495.541,121,623,319.49842,570,309.85
筹资活动现金流出小计557,210,081.7128,726,444.47254,610,530.35235,767,069.44
筹资活动产生的现金流量净额1,776,375,664.35262,617,051.07867,012,789.14606,803,240.41
汇率变动对现金及现金等价物的影响-77,388.6341,823.67-2,449,850.28-247,852.6
现金及现金等价物净增加额994,401,123.572,341,828.7175,963,168.6756,630,389.1
期末现金及现金等价物余额1,244,290,866.2252,231,571.33249,889,742.63130,556,963.06
补充资料:
现金及现金等价物的净增加额994,401,123.57-175,963,168.67-
最新报告期:2025-08-28
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中金公司张琎,刘雅馨,朱言音-1.58-0.81--2025-08-28
中国银河程培,闫晓松-1.38-0.251.112025-08-25
野村东方国际证券孔令岩,肖鸿德-1.36-0.400.582025-08-24
华泰证券代雯,李奕玮-1.34-0.460.752025-08-22
野村东方国际证券孔令岩,肖鸿德-1.37-0.400.582025-07-06
TOP↑